Evidence map›Paper›PMID 35213629›Full record

Trial reportPloS one2022

Etiology of severe invasive infections in young infants in rural settings in sub-Saharan Africa.

Estomih Mduma, Tinto Halidou, Berenger Kaboré, Thomas Walongo, Palpouguini Lompo, Justine Museveni, Joshua Gidabayda, Jean Gratz, Godfrey Guga, Caroline Kimathi and 9 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pathogens Identified by Minimally Invasive Tissue Sampling in India and Pakistan From Preterm Neonatal Deaths: The PURPOSE Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 5 countries.

Estomih MdumaHaydom Research Center, Haydom Lutheran Hospital, Haydom, United Republic of Tanzania.
Tinto HalidouInstitut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.
Berenger KaboréInstitut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.
Thomas WalongoHaydom Research Center, Haydom Lutheran Hospital, Haydom, United Republic of Tanzania.
Palpouguini LompoInstitut de Recherche en Sciences de la Santé (IRSS), Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.
Justine MuseveniHaydom Research Center, Haydom Lutheran Hospital, Haydom, United Republic of Tanzania.
Joshua GidabaydaHaydom Research Center, Haydom Lutheran Hospital, Haydom, United Republic of Tanzania.
Jean GratzDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, United States of America.
Godfrey GugaHaydom Research Center, Haydom Lutheran Hospital, Haydom, United Republic of Tanzania.
Caroline KimathiHaydom Research Center, Haydom Lutheran Hospital, Haydom, United Republic of Tanzania.
Jie LiuDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, United States of America.
Paschal MdoeHaydom Research Center, Haydom Lutheran Hospital, Haydom, United Republic of Tanzania.
Robert MoshiroHaydom Research Center, Haydom Lutheran Hospital, Haydom, United Republic of Tanzania.
Max PetzoldSchool of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Jan SinglovicUNICEF/UNDP/WB/WHO Special Program for Research & Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.
Martine GuillermUNICEF/UNDP/WB/WHO Special Program for Research & Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.
Melba F GomesUNICEF/UNDP/WB/WHO Special Program for Research & Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.
Eric R HouptDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, United States of America.
Christine M HalleuxUNICEF/UNDP/WB/WHO Special Program for Research & Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.ORCID 0000-0002-3230-5541
Haydom Lutheran Hospital · TZWorld Health Organization · CHInstitut de Recherche en Sciences de la Santé · BFUniversity of Virginia · USUniversity of Gothenburg · SE

Funding

Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious DiseasesK24AI102972 · NIAID · UNIVERSITY OF VIRGINIA · PI HOUPT, ERIC R · 2013 to 2022
$1.5M
NIAID NIH HHS K24 AI102972Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

backgroundSerious invasive infections in newborns are a major cause of death. Lack of data on etiological causes hampers progress towards reduction of mortality. This study aimed to identify pathogens responsible for such infections in young infants in sub-Saharan Africa and to describe their antibiotics resistance profile.

methodsBetween September 2016 and April 2018 we implemented an observational study in two rural sites in Burkina Faso and Tanzania enrolling young infants aged 0-59 days old with serious invasive infection. Blood samples underwent blood culture and molecular biology.

resultsIn total 634 infants with clinical diagnosis of serious invasive infection were enrolled and 4.2% of the infants had a positive blood culture. The most frequent pathogens identified by blood culture were Klebsiella pneumonia and Staphylococcus aureus, followed by Escherichia coli. Gram-negative isolates were only partially susceptible to first line WHO recommended treatment for neonatal sepsis at community level. A total of 18.6% of the infants were PCR positive for at least one pathogen and Escherichia coli and Staphylococcus aureus were the most common bacteria detected. Among infants enrolled, 60/634 (9.5%) died. Positive blood culture but not positive PCR was associated with risk of death. For most deaths, no pathogen was identified either by blood culture or molecular testing, and hence a causal agent remained unclear. Mortality was associated with low body temperature, tachycardia, respiratory symptoms, convulsions, history of difficult feeding, movement only when stimulated or reduced level of consciousness, diarrhea and/or vomiting.

conclusionWhile Klebsiella pneumonia and Staphylococcus aureus, as well as Escherichia coli were pathogens most frequently identified in infants with clinical suspicion of serious invasive infections, most cases remain without definite diagnosis, making more accurate diagnostic tools urgently needed. Antibiotics resistance to first line antibiotics is an increasing challenge even in rural Africa.

Indexed as

Rural PopulationAfrica South of the SaharaBacterial InfectionsFemaleHumansInfantInfant, NewbornMalePatient Acuity

Identifiers

PMID35213629
PMCPMC8880396
OpenAlexW4214764902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.